These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
576 related articles for article (PubMed ID: 19961929)
1. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. Misra R; Sahoo SK Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system. Amjadi I; Rabiee M; Hosseini MS; Mozafari M Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852 [TBL] [Abstract][Full Text] [Related]
3. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
4. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
5. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery. Lee JY; Chung SJ; Cho HJ; Kim DD Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin. Li F; Sun J; Zhu H; Wen X; Lin C; Shi D Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271 [TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles. Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637 [TBL] [Abstract][Full Text] [Related]
8. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model. Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558 [TBL] [Abstract][Full Text] [Related]
9. Targeted nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: novel strategy for breast cancer therapy. Das M; Dilnawaz F; Sahoo SK Nanomedicine (Lond); 2011 Apr; 6(3):489-507. PubMed ID: 21542687 [TBL] [Abstract][Full Text] [Related]
10. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery. Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060 [TBL] [Abstract][Full Text] [Related]
11. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers. Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667 [TBL] [Abstract][Full Text] [Related]
12. Lipid-Polymer Nanoparticles for Folate-Receptor Targeting Delivery of Doxorubicin. Zheng M; Gong P; Zheng C; Zhao P; Luo Z; Ma Y; Cai L J Nanosci Nanotechnol; 2015 Jul; 15(7):4792-8. PubMed ID: 26373039 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake. Dong F; Dong X; Zhou L; Xiao H; Ho PY; Wong MS; Wang Y Colloids Surf B Biointerfaces; 2016 Apr; 140():324-331. PubMed ID: 26764113 [TBL] [Abstract][Full Text] [Related]
14. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
15. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model. Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161 [TBL] [Abstract][Full Text] [Related]
16. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery. Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197 [TBL] [Abstract][Full Text] [Related]
17. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation. Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702 [TBL] [Abstract][Full Text] [Related]
18. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Acharya S; Dilnawaz F; Sahoo SK Biomaterials; 2009 Oct; 30(29):5737-50. PubMed ID: 19631377 [TBL] [Abstract][Full Text] [Related]
19. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery. Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700 [TBL] [Abstract][Full Text] [Related]
20. Investigation of novel superparamagnetic Ni Qasim M; Asghar K; Dharmapuri G; Das D Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]